COMP <GO>
INMD vs JNJ // DIVIDEND YIELD & FCF PAYOUT SAFETY
InMode Ltd. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: INMD 4
— JNJ 6
■ METRIC PARITY
LAST: $13.51 (+1.05%) • MKT CAP: $776.6M
dividend-safety
0.00%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INMD VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INMD | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 78.50% | 67.90% | +10.60 | INMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.70% | 25.50% | -7.80 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.5x | 18.5x | -13.00 | INMD | /valuation <GO> |
| Free Cash Flow Yield | 10.85% | 2.97% | +7.88 | INMD | /fcf-yield <GO> |
| Operating Margin | 23.00% | 34.70% | -11.70 | JNJ | /operating-margins <GO> |
| Net Profit Margin | — | 28.50% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -6.20% | 6.00% | -12.20 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.20 | 5.59 | +3.61 | INMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.3 | 62.1 | -25.80 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $776.6M | $662.49B | -$661.72B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INMD REV | JNJ REV | INMD GROSS % | JNJ GROSS % | INMD FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $370.5M | $94.19B | 78.5% | 67.9% | $84.3M | $19.70B |
| FY 2024 | $394.8M | $88.82B | 80.3% | 69.1% | $132.0M | $19.84B |
| FY 2023 | $492.0M | $85.16B | — | — | $176.8M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INMD // BETA —
JNJ // BETA 1.08